KALA BIO, Inc

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALA BIO, Inc and other ETFs, options, and stocks.

About KALA

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases.

CEO

Todd Bazemore

CEOTodd Bazemore

Employees

Employees38

Headquarters

Arlington, Massachusetts

HeadquartersArlington, Massachusetts

Founded

2009

Founded2009

Employees

Employees38

KALA Key Statistics

Market cap

5.65M

Market cap5.65M

Price-Earnings ratio

-0.12

Price-Earnings ratio-0.12

Dividend yield

—

Dividend yield—

Average volume

926.66K

Average volume926.66K

High today

$0.8597

High today$0.8597

Low today

$0.773

Low today$0.773

Open price

$0.773

Open price$0.773

Volume

394.35K

Volume394.35K

52 Week high

$20.60

52 Week high$20.60

52 Week low

$0.773

52 Week low$0.773

People also own

Based on the portfolios of people who own KALA. This list is generated using Robinhood data, and it’s not a recommendation.

KALA BIO, Inc

Why Robinhood?

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. Show more

KALA Key Statistics

People also own

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases.